D. Sheppard

发表

A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia

H. Atkins, D. Allan, B. Zanke, 2015, Leukemia & lymphoma.

Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program.

H. Atkins, D. Allan, L. Huebsch, 2014, JAMA neurology.

Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.

H. Atkins, D. Allan, L. Huebsch, 2016, JAMA neurology.

A Case of Erythrocytosis in a Patient Treated with an Aromatase Inhibitor for Breast Cancer

D. Sheppard, A. Iyengar, 2013, Case reports in hematology.

A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program

D. Allan, L. Huebsch, C. Bredeson, 2014, Bone Marrow Transplantation.

Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies.

D. Allan, C. Bredeson, J. Tay, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haematological problems in obstetrics.

M. Rodger, A. Tinmouth, E. Gándara, 2015, Best practice & research. Clinical obstetrics & gynaecology.

Understanding and improving airway management in companion animals - part 1

D. Sheppard, 2018, Veterinary Nursing Journal.

Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation

H. Atkins, D. Allan, L. Huebsch, 2015, Transfusion.

Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation

L. Huebsch, S. Mcdiarmid, C. Bredeson, 2013, Bone Marrow Transplantation.

Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation.

D. Allan, C. Bredeson, J. Tay, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?

D. Allan, L. Huebsch, S. Mcdiarmid, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Systemic mastocytosis emerging after azacitidine treatment of refractory anaemia with excess blasts type 2

C. Bredeson, D. Sheppard, M. Sabloff, 2014, British Journal of Haematology.

Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.

D. Allan, L. Huebsch, S. Mcdiarmid, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

E. Atenafu, C. Bredeson, J. Finke, 2016, Bone Marrow Transplantation.

Evaluation of an Outpatient Model for Treatment of Acute Myeloid Leukemia

H. Atkins, D. Allan, T. Ramsay, 2016 .

What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation?

L. Huebsch, C. Bredeson, D. Sheppard, 2013, Biology of Blood and Marrow Transplantation.

What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation?

L. Huebsch, C. Bredeson, D. Sheppard, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?

D. Allan, L. Huebsch, S. Mcdiarmid, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.